KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 154 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,568,000 | -22.3% | 1,291,531 | +68.7% | 0.31% | -1.6% |
| Q1 2015 | $9,744,000 | -41.8% | 765,450 | -35.3% | 0.32% | -47.5% |
| Q4 2014 | $16,746,000 | -37.0% | 1,183,484 | -38.8% | 0.60% | -37.9% |
| Q3 2014 | $26,585,000 | -55.5% | 1,933,484 | -50.2% | 0.97% | -59.7% |
| Q2 2014 | $59,742,000 | +149.9% | 3,884,409 | +176.8% | 2.40% | +146.1% |
| Q1 2014 | $23,909,000 | +24.5% | 1,403,105 | -5.4% | 0.98% | -1.9% |
| Q4 2013 | $19,208,000 | -50.5% | 1,483,260 | -61.5% | 1.00% | -44.9% |
| Q3 2013 | $38,839,000 | -11.3% | 3,849,296 | -34.4% | 1.81% | -12.5% |
| Q2 2013 | $43,809,000 | – | 5,864,612 | – | 2.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $16,990,000 | 16.50% |
| VHCP Management, LLC | 1,000,273 | $12,954,000 | 6.97% |
| Cormorant Asset Management, LP | 1,700,000 | $22,015,000 | 6.39% |
| HARVEY CAPITAL MANAGEMENT INC | 890,500 | $11,531,000 | 4.76% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 859,672 | $11,133,000 | 2.50% |
| Rhenman & Partners Asset Management AB | 400,000 | $5,180,000 | 2.03% |
| SECTORAL ASSET MANAGEMENT INC | 2,758,950 | $35,728,000 | 1.54% |
| NORTHPOINTE CAPITAL LLC | 1,289,711 | $16,701,000 | 1.47% |
| Knoll Capital Management, LLC | 200,000 | $2,592,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,483,260 | $19,208,000 | 1.00% |